Literature DB >> 21351618

[Using of transforaminal lumbar interbody fusion in lumbar revision surgery].

Yonghong Hao1, Shucai Deng, Jianjiang Li, Yi Ma.   

Abstract

OBJECTIVE: To analyze the effectiveness of transforaminal lumbar interbody fusion (TLIF) for failed back surgery syndrome (FBSS).
METHODS: Between October 2003 and December 2007, 36 patients with FBSS were treated with TLIF. There were 19 males and 17 females with an average age of 52.6 years (range, 46-68 years) and an average disease duration of 1.6 years (range, 3 months-15 years). Of 36 patients, reoperation was performed in 25, 10 received 3 operations, and 1 had 5 operations. A total of 50 segments were involved in fusion, including L4,5 in 12 cases, L5, S1 in 10 cases, L3, 4 and L4, 5 double segments in 8 cases, and L4, 5 and L5, S1 double segments in 6 cases. According to X-ray films, CT, and MRI examination, 12 patients were diagnosed as having lumbar instability secondary to total laminectomy, 18 as having recurrence of lumbar disc protrusion, and 6 as having recurrence of lumbar spondylolisthesis.
RESULTS: Dural rupture occurred in 1 case and was repaired by suturing without cerebrospinal fluid leakage was observed; 1 had deep incision infection of Staphylococcus; and 1 had transient single irritation sign because of hematoma formation and was cured after symptomatic treatment. The other incisions healed by first intention. No patients had permanent nerve injury or deterioration. Thirty-three cases were followed up 18-72 months (mean, 35.2 months). At 12 months, all the operated segments reached interbody fusion, and no breakage of screw or Cage dislocation occurred. Japanese Orthopaedic Association (JOA) scores showed significant difference (t = 2.45, P = 0.01) between before operation (14.2 +/- 4.1) and 18 months after operation (23.9 +/- 2.6). The rate of clinical improvement was 90.9% (23 cases of excellent, 7 cases of good, 3 cases of acceptable).
CONCLUSION: The TLIF simplifies the manipulation of lumbar revision surgery and decreases the operation risk and the operative complications for the treatment of FBSS.

Entities:  

Mesh:

Year:  2011        PMID: 21351618

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  1 in total

1.  Lumbar interbody fusion with porous biphasic calcium phosphate enhanced by recombinant bone morphogenetic protein-2/silk fibroin sustained-released microsphere: an experimental study on sheep model.

Authors:  Liang Chen; Hai-Long Liu; Yong Gu; Yu Feng; Hui-Lin Yang
Journal:  J Mater Sci Mater Med       Date:  2015-02-18       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.